NDC11 63833082502
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 63833-0825-02 | 63833-0825 |
| 63833-0825-2 | 63833-0825 |
| 63833-825-02 | 63833-825 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Berinert | HUMAN C1-ESTERASE INHIBITOR | CSL Behring GmbH | 8ea0c7fe-da9d-4218-a080-0509e09bedc6 | 2021-09-21 | Warnings, Adverse reactions | 63833-825-02 63833-825 63833082502 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.